These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20713705)

  • 1. beta1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression.
    Huck L; Pontier SM; Zuo DM; Muller WJ
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15559-64. PubMed ID: 20713705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer.
    Denzel MS; Hebbard LW; Shostak G; Shapiro L; Cardiff RD; Ranscht B
    Clin Cancer Res; 2009 May; 15(10):3256-64. PubMed ID: 19447866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo.
    Lahlou H; Sanguin-Gendreau V; Frame MC; Muller WJ
    Breast Cancer Res; 2012 Feb; 14(1):R36. PubMed ID: 22373082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis.
    Wellberg EA; Johnson S; Finlay-Schultz J; Lewis AS; Terrell KL; Sartorius CA; Abel ED; Muller WJ; Anderson SM
    Breast Cancer Res; 2016 Dec; 18(1):131. PubMed ID: 27998284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Redundancy between β1 and β3 Integrin in Activating the IR/Akt/mTORC1 Signaling Axis to Promote ErbB2-Driven Breast Cancer.
    Bui T; Rennhack J; Mok S; Ling C; Perez M; Roccamo J; Andrechek ER; Moraes C; Muller WJ
    Cell Rep; 2019 Oct; 29(3):589-602.e6. PubMed ID: 31618629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β.
    Parvani JG; Galliher-Beckley AJ; Schiemann BJ; Schiemann WP
    Mol Biol Cell; 2013 Nov; 24(21):3449-59. PubMed ID: 24006485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
    Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
    J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.
    Peng M; Ball-Kell SM; Tyner AL
    Cell Death Dis; 2015 Aug; 6(8):e1848. PubMed ID: 26247733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis.
    Deng X; Li Q; Hoff J; Novak M; Yang H; Jin H; Erfani SF; Sharma C; Zhou P; Rabinovitz I; Sonnenberg A; Yi Y; Zhou P; Stipp CS; Kaetzel DM; Hemler ME; Yang XH
    Neoplasia; 2012 Aug; 14(8):678-89. PubMed ID: 22952421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of the 14-3-3σ tumor suppressor is a critical event in ErbB2-mediated tumor progression.
    Ling C; Su VM; Zuo D; Muller WJ
    Cancer Discov; 2012 Jan; 2(1):68-81. PubMed ID: 22585169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors.
    Basak P; Leslie H; Dillon RL; Muller WJ; Raouf A; Mowat MRA
    Genes Chromosomes Cancer; 2018 Apr; 57(4):182-191. PubMed ID: 29218825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of tumor cell integrin alphavbeta3 controls angiogenesis and metastatic growth in the brain.
    Lorger M; Krueger JS; O'Neal M; Staflin K; Felding-Habermann B
    Proc Natl Acad Sci U S A; 2009 Jun; 106(26):10666-71. PubMed ID: 19541645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Catenin haploinsufficiency promotes mammary tumorigenesis in an ErbB2-positive basal breast cancer model.
    Bui T; Schade B; Cardiff RD; Aina OH; Sanguin-Gendreau V; Muller WJ
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):E707-E716. PubMed ID: 28096336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of phenethyl isothiocyanate-mediated mammary cancer chemoprevention in a clinically relevant mouse model.
    Singh SV; Kim SH; Sehrawat A; Arlotti JA; Hahm ER; Sakao K; Beumer JH; Jankowitz RC; Chandra-Kuntal K; Lee J; Powolny AA; Dhir R
    J Natl Cancer Inst; 2012 Aug; 104(16):1228-39. PubMed ID: 22859850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer.
    Pontier SM; Huck L; White DE; Rayment J; Sanguin-Gendreau V; Hennessy B; Zuo D; St-Arnaud R; Mills GB; Dedhar S; Marshall CJ; Muller WJ
    Oncogene; 2010 Jun; 29(23):3374-85. PubMed ID: 20305688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis.
    Guo W; Pylayeva Y; Pepe A; Yoshioka T; Muller WJ; Inghirami G; Giancotti FG
    Cell; 2006 Aug; 126(3):489-502. PubMed ID: 16901783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β1-integrins signaling and mammary tumor progression in transgenic mouse models: implications for human breast cancer.
    Lahlou H; Muller WJ
    Breast Cancer Res; 2011; 13(6):229. PubMed ID: 22264244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression.
    Schade B; Lesurf R; Sanguin-Gendreau V; Bui T; Deblois G; O'Toole SA; Millar EK; Zardawi SJ; Lopez-Knowles E; Sutherland RL; Giguère V; Kahn M; Hallett M; Muller WJ
    Cancer Res; 2013 Jul; 73(14):4474-87. PubMed ID: 23720052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Generation and comparison of two genetically engineered mouse models of ErbB2/Neu positive-PTEN deficient breast cancer].
    Wang QF; Ding H; Liu BR; Zhang K
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 43(4):427-33. PubMed ID: 25187457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mena deficiency delays tumor progression and decreases metastasis in polyoma middle-T transgenic mouse mammary tumors.
    Roussos ET; Wang Y; Wyckoff JB; Sellers RS; Wang W; Li J; Pollard JW; Gertler FB; Condeelis JS
    Breast Cancer Res; 2010; 12(6):R101. PubMed ID: 21108830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.